Wide Ranks

CELZ

Creative Medical Technology Hol

2.65

Top Statistics
Market Cap 4 M Forward PE -1.18 Revenue Growth 0.00 %
Current Ratio 19.13 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.2920 Enterprise / Revenue -146.62 Price To Sales Trailing12 Months 421.07
Profitability
Profit Margins 0.00 % Operating Margins -51181.51 %
Balance Sheet
Total Cash 6 M Total Cash Per Share 3.58 Total Debt 14194
Total Debt To Equity 0.2160 Current Ratio 19.13 Book Value Per Share 4.93
All Measures
Short Ratio 57.00 % Message Board Id finmb_326119455 Shares Short Prior Month 29587
Return On Equity -0.5703 City Phoenix Uuid cac5f784-ef0d-3490-a93e-338be41d8d2c
Previous Close 2.69 First Trade Date Epoch Utc 1 B Book Value 4.93
Total Debt 14194 Volume 17467 Price To Book 0.5375
Last Split Date 1 B Fifty Two Week Low 2.41 Total Cash Per Share 3.58
Total Revenue 11000 Shares Short Previous Month Date 1 B Target Median Price 30.00
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -51181.51 %
Target Mean Price 30.00 Net Income To Common -5317981 Short Percent Of Float 0.0227
Implied Shares Outstanding 1 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 20450 Average Volume10days 20450 Total Cash 6 M
Next Fiscal Year End 1 B Revenue Per Share 0.0080 Held Percent Insiders 0.0210
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 2.69 Target Low Price 30.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 3.34 Open 2.70 Free Cashflow -3660728
State AZ Dividend Yield 0.00 % Return On Assets -0.3627
Time Zone Short Name EST Trailing Eps -3.80 Day Low 2.60
Address1 211 East Osborn Road Shares Outstanding 1 M Price Hint 4
Target High Price 30.00 Website https://www.creativemedicaltechnology.com 52 Week Change -0.4045
Average Volume 37353 Forward Eps -2.58 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 1891.90 % Last Split Factor 1:10
Regular Market Day High 2.80 Is_sp_500 False Profit Margins 0.00 %
Debt To Equity 0.2160 Fifty Two Week High 10.28 Day High 2.80
Shares Short 38901 Regular Market Open 2.70 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue -146.62 Revenue Growth 0.00 %
Shares Percent Shares Out 0.0222 Operating Cashflow -5246739 Currency USD
Time Zone Full Name America/New_York Market Cap 4 M Is_nasdaq_100 False
Zip 85012 Quote Type EQUITY Industry Biotechnology
Long Name Creative Medical Technology Holdings, Inc. Regular Market Day Low 2.60 Held Percent Institutions 0.0396
Current Price 2.65 Enterprise To Ebitda 0.2920 Financial Currency USD
Current Ratio 19.13 Gross Margins 60.00 % Industry Disp Biotechnology
Number Of Analyst Opinions 1 Country United States Float Shares 1 M
Two Hundred Day Average 3.98 Enterprise Value -1612809 Price To Sales Trailing12 Months 421.07
Forward PE -1.18 Regular Market Volume 17467 Ebitda -5516632
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.

It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure.

In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease.

Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.